News

nCLE Solution for Applications in Lung Cancer and Other Pulmonary Diseases during ERS 2018

13 September 2018
  • The availability of the needle-based Cellvizio platform, now bearing CE mark, could be a game changer for the management of patients with certain pulmonary diseases including lung cancer.
  • Ground-breaking work from the interventional pulmonology team at the Amsterdam Academic Medical Center will be highlighted among five other presentation sessions during ERS, the largest meeting of respiratory professionals in the world.

Mauna Kea Technologies today announced the introduction of its needle-based Cellvizio solution for use in lung cancer and respiratory diseases applications during the European Respiratory Society (ERS) International Congress 2018, being held September 15-19, in Paris, France.

During the congress, there will be an oral presentation from Dr. Lizzy Wijmans, Amsterdam, Netherlands on the topic of needle-based Confocal Laser Endomicroscopy (nCLE) for Diagnosing Malignant Pleural Mesothelioma, showing positive results for Cellvizio. There are also five additional presentations using needle-based Confocal Laser Endomicroscopy across different indications showing the growing momentum of the Cellvizio platform in pulmonology.

“Our presence and robust presentation schedule at this year’s ERS congress reflects the introduction of our ground-breaking needle-based endomicroscopy solution in the lung disease space. These presentations add to the growing body of evidence for Cellvizio as a valuable tool for the detection, diagnosis and treatment management of a range of pulmonary diseases,” said Sacha Loiseau, Ph.D., Founder and Chief Executive Officer of Mauna Kea Technologies. “In particular, the unique ability of Cellvizio to get to the core of pulmonary lesions through a needle is a unique offer which could dramatically improve the management of patients with suspicion of lung cancer. This opens up important possibilities for Cellvizio in the management of the second most prevalent cancer worldwide.”

Featured Presentations include:

  • Needle Based Confocal Laser Endomicroscopy (nCLE) for Diagnosing Malignant Pleural Mesothelioma
    Session 77; Presentation OA496
    Oral Presentation: Pleural disease – diagnosis, monitoring and management
    Date, Time: Sunday, September 16 at 11:30-11:45 a.m. CET
    Room: 7.3Q
    Presenting Author: Dr. Lizzy Wijmans, Amsterdam, Netherlands
  • Confocal Laser Endomicroscopy (CLE) as a Guidance Tool for Transbronchial Lung Cryobiopsies in ILD
    Session 249; Presentation OA2163
    Oral Presentation: Interventional pulmonology highlights in 2018 – latest innovations
    Date, Time: Monday, September 17 at 10:45-11:00 a.m. CET
    Room: 7.3P
    Presenting Author: Dr. Lizzy Wijmans, Amsterdam, Netherlands
  • Probe-based Confocal Laser Endomicroscopy in Differential Diagnosis of Interstitial Lung Disease (ILD)
    Session 350; Presentation PA3377
    Poster Discussion: Cryobiopsy in interstitial lung disease (ILD)
    Date, Time: Monday, September 17; at 14:45-16:45 p.m. CET
    Room: 7.2C
    Presenting Author: Dr. Igor Mamenko, St. Petersburg, Russian Federation
  • First Procedure: Confocal Endoscopy Lesions
    Session 372
    Oral Session: Pulmonary Endoscopy – Lung cancer and the pleural diseases
    Date, Time: Tuesday, September 18; at 8:30-9:00 a.m. CET
    Room: 7.3A
    Session Chair and Presenting Author: Prof. Luc Thiberville, Rouen, France
  • Confocal Laser Endomicroscopy (CLE) for Differentiating the Underlying Cause of Ground Glass Opacities in ILD Patients
    Session 388; Presentation PA3655
    Poster Discussion: CTD-ILD and hypersensitivity pneumonitis – from the bench to the bedside
    Date, Time: Tuesday, September 18 at 8:30-10:30 a.m. CET
    Room: 7.2B
    Presenting Author: Dr. Lizzy Wijmans, Amsterdam, Netherlands
  • Probe-based Confocal Laser-Endomicroscopy Imaging of Differential Auto-Fluorescence of Alveolar Macrophages in Diffuse Lung Diseases
    Session 466; Presentation PA4801
    Thematic poster: Back to basics and translational research in idiopathic interstitial pneumonia
    Date, Time: Tuesday, September 18 at 12:50-14:40 p.m. CET
    Room: TP-45
    Presenting Author: Prof. Dr. Kazuyoshi Imaizumi, Toyoake, Japan

Latest News

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio 

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio